NUS

Nu Skin Enterprises, Inc. · NYSE · Consumer Defensive · USD · 10-K for 2025, filed 2026-02-13

Figures on this page computed 2026-11-08 12:40 UTC

Last close

4.99USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-13

1.3xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-13
The filing itself
6.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
- 10-K for 2025, filed 2026-02-13
- 10-K for 2025, filed 2026-02-13
- 10-K for 2025, filed 2026-02-13
- 10-Q for 2025, filed 2026-08-10
- 10-K for 2025, filed 2026-02-13
- 10-Q for 2025, filed 2026-08-10
The filing itself
10.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
- 10-K for 2025, filed 2026-02-13
- 10-K for 2025, filed 2026-02-13
The filing itself
3.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
- 10-K for 2025, filed 2026-02-13
- 10-K for 2025, filed 2026-02-13
The filing itself
0.38Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
- 10-K for 2025, filed 2026-02-13
- 10-Q for 2025, filed 2026-08-10
The filing itself
5.8%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-02-13

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

Against its rival

lens 4 of 9

Measure by measure

behind on 1 of 4

Profit on each unit of sales10.8%5.2%Ahead
Higher is better here.
Return on the capital it uses6.2%n/an/a
Higher is better here.
Sales growth over five years-10.5%3.7%Behind
Higher is better here.
Debt against equity0.38n/an/a
Lower is better here.
Gross margin69.5%39.4%Ahead
Higher is better here.
Price against earnings1.3x25.4xAhead
Lower is better here.

The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.

Against Acme United Corporation, NUS is behind on 1 of 4 measures.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-13

Profit on each unit of sales10.8%
Source
filed
Statement
income
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
The filing itself
Return on the capital it uses6.2%
Source
filed
Statement
income
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
The filing itself
Sales growth over five years-10.5%
Source
filed
Statement
income
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
The filing itself
Debt against equity0.38
Source
filed
Statement
income
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
The filing itself
Gross margin69.5%
Source
filed
Statement
income
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
The filing itself
Price against earnings1.3x
Source
filed
Statement
income
Fiscal year
2025
Accession
0001140361-26-005130
Reported in
USD
The filing itself